• CCK8–NOX4 Signaling Drives ANP Secretion

  2026-10-09

  The 2022 study by Han and colleagues identifies a redox-sensitive pathway through which sulfated cholecystokinin octapeptide promotes atrial natriuretic peptide release in isolated beating rat atria. Its central contribution is to connect CCK receptor activity with arachidonic acid signaling, NOX4-derived hydrogen peroxide, PGC-1α, and PPARα/PPARγ, while also showing feedback regulation by ANP.

• PPM-18 and the NF-κB–iNOS Evidence Gap

  2026-10-08

  PPM-18 is a chemically synthesized naphthoquinone derivative used to investigate NF-κB-regulated iNOS expression. This article distinguishes supplier-reported activity from peer-reviewed evidence and explains what an oridonin bone-remodeling study can—and cannot—tell us about inflammation, immune response modulation, and sepsis research.

• PPM-18, NF-κB and iNOS: Research Context

  2026-10-08

  A source-grounded overview of PPM-18 and N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide, emphasizing reported NF-κB–iNOS findings, conceptual applications in inflammation and sepsis research, comparison with a peer-reviewed oridonin bone-remodeling study, and key evidence limitations.

• PTT and CD47 Blockade in Oral Cancer

  2026-10-07

  A 2026 study shows that photothermal therapy can strengthen CD47 blockade in oral squamous cell carcinoma by pairing a macrophage-activating eat-me signal with extracellular-matrix remodeling that improves tumor access. The preclinical findings support a dual-barrier model of treatment synergy, while leaving questions about clinical translation, mechanism-specific causality, and treatment safety.

• Irinotecan: Connecting Tumor Killing to Liver Toxicity

  2026-10-07

  Irinotecan research is increasingly understood through two linked phenotypes: tumor DNA damage and chemotherapy-associated gut–liver injury. This evidence-centered analysis connects CPT-11 pharmacology with intestinal barrier dysfunction, LPS signaling, and neutrophil extracellular traps while defining the limits of preclinical interpretation.

• Sunitinib in RTK and Tumor Angiogenesis Research

  2026-10-06

  A source-grounded overview of Sunitinib as a multi-targeted receptor tyrosine kinase inhibitor, its conceptual use in angiogenesis and cancer-model research, and the limits of connecting oncology pharmacology with recent Zika virus phosphoproteomics findings.

• Sulfo-Cy3 NHS Ester: Evidence, Scope and Limits

  2026-10-06

  A source-grounded overview of Sulfo-Cy3 NHS Ester, the principles behind amine-reactive fluorescent labeling, and what a recent collateral-circulation study does—and does not—show about interpreting fluorescence in vascular biology.

• Chloroquine in Cancer Therapy: Review Findings

  2026-10-05

  The 2024 review by Liu and colleagues examines how Chloroquine may influence cancer biology through both autophagy-dependent and autophagy-independent mechanisms. Its main contribution is a broad pharmacological synthesis linking lysosomal effects, cell-death pathways, combination therapy, toxicity, and translational limitations rather than treating autophagy inhibition as a complete explanation.

• Chloroquine Diphosphate in Cancer Research: Evidence

  2026-10-05

  This source-grounded overview examines Chloroquine Diphosphate as an autophagy and endosomal-pathway research tool, while separating supplier claims from peer-reviewed findings. It places the compound alongside a 2023 colorectal cancer study involving 3-bromopyruvate and cetuximab, explains possible conceptual applications in autophagy assay design and treatment-response research, and defines the evidence boundaries that prevent conclusions about chloroquine-specific cancer efficacy.

• AMPK–p62 Feedback Under Metabolic Stress

  2026-10-04

  Choi and colleagues identify a double-positive feedback loop linking AMPK and SQSTM1/p62 during metabolic stress, allowing coordinated activation of AMPK-dependent energy adaptation and NFE2L2/NRF2 antioxidant defense. The study connects lysosomal stress, KEAP1 degradation, TFEB/TFE3 regulation, and TAK1 signaling, while also defining important boundaries around the effects of lactic-acid-associated proton availability.

• WZ4003: NUAK1/2 Inhibitor Evidence Guide

  2026-10-03

  WZ4003 is a NUAK1/2 inhibitor with reported nanomolar biochemical potency and cellular evidence of NUAK pathway engagement. Peer-reviewed ex vivo brain-slice data link NUAK inhibition with lower tau Ser356 phosphorylation, while model-specific limitations prevent direct claims of therapeutic efficacy.

• TCF25 Links Lysosomal Acidification to Cell Death

  2026-10-01

  Ren et al. identify TCF25 as a nutrient-responsive regulator that strengthens V-ATPase-dependent lysosomal acidification during glucose starvation. The study shows that this response initially supports autophagy and ATP production but, during prolonged starvation, drives ferritinophagy, lysosomal membrane permeability, and lysosome-dependent cell death, with implications for hepatic ischemia-reperfusion injury.

• Triamcinolone: In Vitro Workflow and QC Guide

  2026-10-01

  Triamcinolone (B1859) provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solubility, stock preparation, storage, and assay controls; the research compound is not intended for diagnostic, therapeutic, or clinical use.

• CCK-8 Restores Morphine-Impaired Hippocampal LTP

  2026-09-30

  The reference study showed that intracerebroventricular CCK-8 restored hippocampal long-term potentiation weakened by acute morphine exposure in rats. Pharmacological blockade identified CCK2, rather than CCK1, receptors as the principal mediators, providing a mechanistic link between brain–gut peptide signaling, synaptic plasticity, and morphine-associated memory impairment.

• Oligo (dT) 25 Beads: mRNA Purification Guide

  2026-09-30

  Oligo (dT) 25 Beads provide a magnetic workflow for capturing polyadenylated eukaryotic mRNA from total RNA or animal and plant samples. They are not a universal RNA purification reagent and should not be used as the sole strategy for non-polyadenylated RNA, small RNA, or bacterial transcriptome recovery.

8642 records 1/577 page Next 12345 下5页 Last page